Cancer survivors find mobile devices and websites difficult to use

Megan, a woman in her early 40s, was diagnosed with breast cancer last year and began a course of chemotherapy that has left her with persistent cognitive difficulties. After the treatment, she reports significant brain fog, trouble concentrating, and an inability to recall names, locate everyday items such as keys or her phone, and follow even simple, long‑handed instructions. The symptoms have disrupted her daily routine and affected her confidence in managing routine tasks.

The cognitive side effects Megan describes are consistent with what researchers call “chemo brain,” a well‑documented phenomenon in which chemotherapy can impair memory, attention, and executive function. Studies show that up to 70% of patients experience some degree of cognitive decline during or after treatment, with many reporting similar challenges in remembering personal details and navigating everyday activities. Megan’s experience underscores the broader impact of these side effects on patients’ quality of life and the need for targeted support strategies.

As Megan navigates the aftermath of her treatment, her case highlights the importance of early recognition and management of chemotherapy‑related cognitive impairment. Healthcare providers are increasingly encouraged to screen for these symptoms and offer interventions such as cognitive rehabilitation, memory aids, and counseling to help patients maintain independence and reduce the burden on caregivers.